GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 225 filers reported holding GENMAB A/S in Q4 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $33,498 | -16.0% | 1,333 | 0.0% | 0.01% | -20.0% |
Q1 2024 | $39,870 | -6.1% | 1,333 | 0.0% | 0.02% | -11.8% |
Q4 2023 | $42,443 | -9.7% | 1,333 | 0.0% | 0.02% | -22.7% |
Q3 2023 | $47,015 | -7.2% | 1,333 | 0.0% | 0.02% | 0.0% |
Q2 2023 | $50,667 | +0.7% | 1,333 | 0.0% | 0.02% | -8.3% |
Q1 2023 | $50,334 | -10.9% | 1,333 | 0.0% | 0.02% | -17.2% |
Q4 2022 | $56,493 | +31.9% | 1,333 | 0.0% | 0.03% | +20.8% |
Q3 2022 | $42,829 | -1.1% | 1,333 | 0.0% | 0.02% | 0.0% |
Q2 2022 | $43,309 | -10.2% | 1,333 | 0.0% | 0.02% | +4.3% |
Q1 2022 | $48,228 | -8.5% | 1,333 | 0.0% | 0.02% | -8.0% |
Q4 2021 | $52,733 | -9.5% | 1,333 | 0.0% | 0.02% | -13.8% |
Q3 2021 | $58,252 | -50.8% | 1,333 | -54.0% | 0.03% | -50.0% |
Q2 2021 | $118,366 | +3983.0% | 2,899 | -97.0% | 0.06% | -59.7% |
Q1 2021 | $2,899 | -97.5% | 95,174 | +3183.0% | 0.14% | +114.9% |
Q4 2020 | $117,873 | +11.1% | 2,899 | 0.0% | 0.07% | -4.3% |
Q3 2020 | $106,132 | – | 2,899 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 214,848 | $6,980,000 | 2.38% |
Cutter & CO Brokerage, Inc. | 119,956 | $3,897,000 | 1.33% |
Hardman Johnston Global Advisors LLC | 933,449 | $30,328,000 | 1.29% |
Connective Portfolio Management, LLC | 18,000 | $585,000 | 1.00% |
Capricorn Fund Managers Ltd | 148,411 | $4,822,000 | 0.88% |
TORRAY INVESTMENT PARTNERS LLC | 131,708 | $4,279,000 | 0.82% |
First Light Asset Management, LLC | 160,885 | $5,227,000 | 0.61% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,857 | $57,189,000 | 0.60% |
Yorktown Management & Research Co Inc | 10,100 | $328,000 | 0.42% |
Integrated Investment Consultants, LLC | 18,550 | $602,000 | 0.22% |